In addition, several PCAT19-containing prognostic models, such as a TIME-related signature in stomach adenocarcinoma (Zhu et al., 2022), necroptosis-related lncRNA signatures in bladder cancer (Jin et al., 2023), and necroptosis-related lncRNA signatures in uterine corpora endometrial cancer (Lin Z. et al., 2023), have been developed and demonstrated significant prognostic value in these cancers. This evidence concerns the gene PCAT19 and endometrial cancer.